37 results on '"Hao, Yating"'
Search Results
2. Rapid Detection of Paclitaxel-Induced Changes in Cervical Cancer Cells Using an Ultrasensitive Biosensor
3. Machine Learning Algorithm-Based Prediction of Hyperglycemia Risk After Acute Ischemic Stroke
4. Exact solutions to the (3+1)-dimensional time-fractional KdV–Zakharov–Kuznetsov equation and modified KdV equation with variable coefficients
5. Crystal structure of 6,6′-((1E,1′E)-((2-phenylpyrimidine-4,6-diyl)bis(hydrazin-2-yl-1-ylidene))bis(methaneylylidene))bis(2-methoxyphenol)monohydrate, C26H26N6O5
6. Long non-coding RNA HANR modulates the glucose metabolism of triple negative breast cancer via stabilizing hexokinase 2
7. Particle flow regime in a swirling pneumatic conveying system
8. Exact solutions to the $$(3 + 1)$$-dimensional time-fractional KdV–Zakharov–Kuznetsov equation and modified KdV equation with variable coefficients
9. Cancer cell‐derived exosomal miR‐20a‐5p inhibits CD8+ T‐cell function and confers anti‐programmed cell death 1 therapy resistance in triple‐negative breast cancer
10. Cancer cell‐derived exosomal miR‐20a‐5p inhibits CD8+ T‐cell function and confers anti‐programmed cell death 1 therapy resistance in triple‐negative breast cancer.
11. The Effect of a Three-Blade Tube on the Pneumatic Transport of Pebble Particles.
12. Crystal structure of 6,6′-((1E,1′E)-((2-phenylpyrimidine-4,6-diyl)bis(hydrazin-2-yl-1-ylidene))bis(methaneylylidene))bis(2-methoxyphenol)monohydrate, C26H26N6O5.
13. Crystal structure of 6,6′-((1E,1′E)-((2-phenylpyrimidine-4,6-diyl)bis(hydrazin-2-yl-1-ylidene))bis(methaneylylidene))bis(2-methoxyphenol)monohydrate, C26H26N6O5.
14. Synthesis, Biological Evaluation, DNA Binding, and Molecular Docking of Hybrid 4,6-Dihydrazone Pyrimidine Derivatives as Antitumor Agents
15. Comparison of Axial Flow and Swirling Flow on Particle Pickup in Horizontal Pneumatic Conveying
16. Reduced PTEN involved in primary immune thrombocytopenia via contributing to B cell hyper-responsiveness
17. Increased plasma sCXCL16 levels may have a relationship with Th1/Th2 imbalance in primary immune thrombocytopenia
18. Synthesis, Biological Evaluation, DNA Binding, and Molecular Docking of Hybrid 4,6-Dihydrazone Pyrimidine Derivatives as Antitumor Agents.
19. MiR-133 Targets YES1 and Inhibits the Growth of Triple-Negative Breast Cancer Cells
20. Numerical and functional defects in CD8+CD28−T-suppressor lymphocytes from patients with primary immune thrombocytopenia
21. Upregulation of CD72 expression on CD19+CD27+memory B cells by CD40L in primary immune thrombocytopenia
22. Decreased TLR4 expression on monocytes may cause regulatory T cells abnormality in patients with primary immune thrombocytopenia
23. Decreased immunosuppressive actions of 1α, 25-dihydroxyvitamin D3 in patients with immune thrombocytopenia
24. Effects of the multidrug resistance-1 gene on drug resistance in primary immune thrombocytopenia
25. Aberrant expression of long noncoding RNA TMEVPG1 in patients with primary immune thrombocytopenia
26. Stromal cell-derived factor-1 rs2297630 polymorphism associated with platelet production and treatment response in Chinese patients with chronic immune thrombocytopenia
27. Elevated Semaphorin 5A correlated with Th1 polarization in patients with chronic immune thrombocytopenia
28. Numerical and functional defects in CD8+CD28− T-suppressor lymphocytes from patients with primary immune thrombocytopenia.
29. Upregulation of CD72 expression on CD19+CD27+ memory B cells by CD40L in primary immune thrombocytopenia.
30. Stromal cell-derived factor-1 rs2297630 polymorphism associated with platelet production and treatment response in Chinese patients with chronic immune thrombocytopenia.
31. The risk assessment method oriented to mechanical safety design
32. Cancer cell-derived exosomal miR-20a-5p inhibits CD8 + T-cell function and confers anti-programmed cell death 1 therapy resistance in triple-negative breast cancer.
33. Long non-coding RNA HANR modulates the glucose metabolism of triple negative breast cancer via stabilizing hexokinase 2.
34. Numerical and functional defects in CD8 + CD28 - T-suppressor lymphocytes from patients with primary immune thrombocytopenia.
35. Upregulation of CD72 expression on CD19 + CD27 + memory B cells by CD40L in primary immune thrombocytopenia.
36. Decreased immunosuppressive actions of 1α, 25-dihydroxyvitamin D 3 in patients with immune thrombocytopenia.
37. [Lupus anticoagulant: two cases report and literature review].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.